The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related disease.
The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.
The Pharmacy Residency Program is an ASHP-accredited PGY-2 oncology pharmacy residency designed to provide the resident with opportunities to develop clinical competence in oncology pharmacy practice. The resident will gain experience in the following areas of practice:
Through these educational experiences, residents will:
Research projects will be determined according to the resident's interest and department needs. The resident will be required to complete one project to be presented at a national meeting (HOPA).
Examples of past resident research projects:
Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes.
In addition, pharmacy residents will be invited to attend professional conferences, including:
The resident will spend approximately ten months completing core rotations, and is allotted two months for elective experiences and research.
Bridget Fowler Scullion, PharmD, BCOPClinical Pharmacy ManagerEducation: St. Louis College of Pharmacy
Sylvia B. Bartel, RPh, MHPVice President of Pharmacy ServicesEducation: University of Wisconsin
Christy S. Harris, PharmD, BCPS, BCOPAssistant Professor – MCPHS University, Clinical Pharmacy SpecialistEducation: University of Tennessee Health Sciences
Anne McDonnell, PharmD, BCOPInpatient Clinical Pharmacy SpecialistEducation: University of Arkansas for Medical Sciences
Caroline Harvey, RPhResearch Pharmacy ManagerEducation: Northeastern University
Andrew Skirvin, BS, PharmD, BCOPAssociate Clinical Professor – Northeastern University, Hematology/Oncology Clinical PharmacistEducation: University of Texas Health Science Center
Audrea Szabatura, PharmD, BCOPMedication Safety OfficerEducation: University of Connecticut
Victor Phantumvanit, PharmD, BCPs, BCOPClinical Pharmacy SpecialistEducation: University of Maryland, School of Pharmacy
Theresa LeFrancois, PharmD, BCOPPediatric Oncology Clinical PharmacistEducation: Massachusetts College of Pharmacy and Health Sciences
Pharm.D degree and ASHP accredited PGY1 pharmacy residency required, with experience in oncology preferred. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.
Please submit your application through PhORCAS — https://portal.phorcas.org/:
Deadline for applying: First Friday in JanuaryResidency start date: First Monday following the 4th of July holiday
For more information, please contact:
Bridget Fowler Scullion, PharmDResidency Program Director / Clinical Pharmacy Managerbridget_scullion@dfci.harvard.edu
Sylvia Bartel, RPh, MPHVice President of Pharmacysylvia_bartel@dfci.harvard.edu
Search by last name:
Browse directory of
Search jobsLearn how to apply
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: